The arthritis drug tocilizumab doesn’t appear to help fight COVID-19
Additional clinical trials are still assessing the anti-inflammatory drug
![tocilizumab](https://i0.wp.com/www.sciencenews.org/wp-content/uploads/2020/10/102220_ac_covid-inflammation_feat.jpg?fit=1028%2C579&ssl=1)
The drug tocilizumab is a treatment for rheumatoid arthritis. A number of clinical trials have been investigating whether its anti-inflammatory properties could aid patients hospitalized with COVID-19.
Marc Bruxelle/Alamy Stock Photo